A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
Clinical trial NCT00541450 · COMPLETED
Trial details
- NCT number
- NCT00541450
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-15
- Primary completion
- 2010-01-08
- Enrollment
- 492
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.